Top Image
Advanced Centre for Treatment Research & Education in Cancer
Facebook Twitter Gmail
Banner Image
Science Sparks @ ACTREC
Date Image 19th September 2022 Vol. No. 11; Issue No. 544

1. Saikia D, Jadhav P, Hole A, CM Krishna, Singh SP (2022). Unraveling the secrets of colistin resistance with label-free Raman Spectroscopy. Biosensors. 12(9): 749.

2. Mal A, Prabhuraj RS, Malhotra R, Valvi S, Ingle A, Srivastava R, De A, Bandopadhyaya R (2022). pH-responsive sustained delivery of doxorubicin using aminated and PEGylated mesoporous silica nanoparticles leads to enhanced antitumor efficacy in pre-clinical orthotopic breast cancer model. Journal of Drug Delivery Science and Technology.

3. Chakraborty N, Jain BK, Shembekar S, Bhattacharyya D (2022). ER exit sites (ERES) and ER-mitochondria encounter structures (ERMES) often localize proximally. FEBS Letters.

Site of the Week

MODOMICS is a a manually curated and centralized resource, storing and distributing comprehensive information about modified ribonucleosides.

desktop Image
Interesting Reads

Schmitt CA, Wang B, Demaria M (2022). Senescence and cancer - role and therapeutic opportunities. Nat Rev Clin Oncol.

Legends of Science
 	Madhavasetty Ramalingam Rajasekarasetty Madhavasetty Ramalingam Rajasekarasetty

M R Rajasekarasetty received his Ph.D. from the University of Columbia, USA, in 1952. His major contributions included population genetics, radiation cytology, and the effect of physical and chemical agents on germ-line cells. His qualitative and quantitative work; on X-ray-induced meiotic chromosomal aberrations laid the foundation for a better understanding of chromosome structure, mechanisms involved in the production of various anomalies, dose-yield and time-yield relationships of aberrations, and inter-relationships of these aberrations. Dr. Rajasekarasetty was elected fellow of the Indian Academy of Sciences, Bangalore; National Academy of Sciences, Allahabad.

Vishwa Nath Vishwa Nath

Vishwa Nath obtained his Ph.D. from the University of Cambridge, the UK, in 1925. His major study was on the reproductive organs of scorpions and mosquitoes. He demonstrated that the spermatozoon explodes at the time of fertilization and transforms into its typical weird form. He was the President of the Indian Science Congress in 1944. He was the elected fellow of the Royal Microscopical Society, London. The Indian National Science Academy has instituted the 'Vishwa Nath Memorial Lecture' in his honor.

Upcoming Events
International Human Gene Therapy Conference

26-28 September, 2022

At Melbourne, Australia.

3rd Cytogenetics Workshop 2022

16-18 November, 2022

At ACTREC, Tata Memorial Centre, Kharghar, Navi Mumbai-410210.

Jaipur Surgical Festival

02-04 December, 2022

At Mahatma Gandhi Medical College & Hospital (MGMCH), Jaipur and Online.

Do You Know?

In 2006, Using advanced molecular classification techniques to examine tumor samples, researchers discovered distinct subtypes of high-grade astrocytoma tumors( a form of glioma).

back Image
Cancer News
Key mechanisms to improve intestinal regeneration and alleviate the side effects of radiotherapy discovered

14 September 2022, MedicalXpress

Researchers at the Spanish National Cancer Research Centre (CNIO) have now discovered one of the cellular and molecular mechanisms essential for the regeneration of the intestinal epithelium...

India removes Ranitidine, and Zinetac from the essential medicines list over cancer concerns

14 September 2022, Times Now

The Indian government has removed a few popular medicines from the national list of essential medicines, over concerns related to cancer. A total of 384 drugs have been included in the list with the addition of 34 drugs, while 26 from the previous list have been dropped...

Experimental test promises to predict side-effects and cancer’s return in patients treated with immunotherapy

15 September 2022, EurekAlert

The research team theorized that certain patients might have higher levels of key autoantibodies prior to treatment but not enough to be detected as autoimmune disease. This hidden susceptibility, they hypothesized, would then be triggered by checkpoint inhibitors to cause greater immune-based side effects...

� 2022 Advanced Centre for Treatment, Research and Education in Cancer (ACTREC)